William Grossman

Sr. VP, Chief Medical Officer, BELLICUM PHARMACEUTICALS, INC.

Companies

enGene Therapeutics Inc.Interim Chief Medical Officer Jun 17, 2026 to now¹
enGene Therapeutics Inc.Board member Jul 8, 2025 to now²
Day One Biopharmaceuticals, Inc.Board member Jan 19, 2024 to now³
Arcus BiosciencesChief Medical Officer May 1, 2019 to Jun 21, 2021⁴
BELLICUM PHARMACEUTICALS, INCSr. VP, Chief Medical Officer Feb 7, 2018 to Feb 7, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

enGene Therapeutics Inc. ENGN5,102 shares⁶$8.5K at $1.67Sep 22, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 22, 2026Bought 5,102 shares at $1.97 of enGene Therapeutics Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARenGene Therapeutics Inc., Interim Chief Medical Officer
2
SEC EDGARenGene Therapeutics Inc., Board member
3
SEC EDGARDay One Biopharmaceuticals, Inc., Board member
4
SEC EDGARArcus Biosciences, Chief Medical Officer
5
SEC EDGARBELLICUM PHARMACEUTICALS, INC, Sr. VP, Chief Medical Officer
6
SEC EDGARenGene Therapeutics Inc. shares after the filing of Sep 22, 2026